Prelude Therapeutics Inc - Common Stock, $0.0001 par value per share (PRLD)
CUSIP: 74065P101
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 65,427,364
- Total 13F shares
- 27,161,835
- Share change
- -26,120
- Total reported value
- $39,111,943
- Price per share
- $1.44
- Number of holders
- 45
- Value change
- +$249,044
- Number of buys
- 12
- Number of sells
- 30
Quarterly Holders Quick Answers
What is CUSIP 74065P101?
CUSIP 74065P101 identifies PRLD - Prelude Therapeutics Inc - Common Stock, $0.0001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74065P101:
Top shareholders of PRLD - Prelude Therapeutics Inc - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
17%
|
10,909,256
|
$8,829,952 | — | 30 Jun 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
15%
|
10,123,824
|
$8,194,223 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.4%
|
932,570
|
$754,450 | — | 30 Jun 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.4%
|
927,608
|
$743,000 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.89%
|
581,800
|
$470,909 | — | 30 Jun 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.83%
|
540,565
|
$436,000 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.66%
|
432,559
|
$350,112 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.43%
|
284,382
|
$230,179 | — | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.38%
|
248,423
|
$201,074 | — | 30 Jun 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.34%
|
225,000
|
$182,115 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.33%
|
217,568
|
$176,135 | — | 30 Jun 2025 | |
| CANTOR FITZGERALD, L. P. |
13F
|
Individual |
0.32%
|
211,859
|
$171,479 | — | 30 Jun 2025 | |
| Laurent Chardonnet |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
192,165
mixed-class rows
|
$158,962 | — | 01 Mar 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.25%
|
160,652
|
$130,032 | — | 30 Jun 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.24%
|
154,977
|
$125,438 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.23%
|
149,178
|
$120,745 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.16%
|
104,204
|
$84,301 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.15%
|
97,592
|
$78,991 | — | 30 Jun 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.14%
|
91,753
|
$74,265 | — | 30 Jun 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.14%
|
88,500
|
$71,632 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.12%
|
80,845
|
$65,436 | — | 30 Jun 2025 | |
| Shay Capital LLC |
13F
|
Company |
0.11%
|
75,000
|
$60,705 | — | 30 Jun 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.11%
|
71,378
|
$58,000 | — | 30 Jun 2025 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.11%
|
69,252
|
$56,053 | — | 30 Jun 2025 | |
| Y-Intercept (Hong Kong) Ltd |
13F
|
Company |
0.07%
|
47,788
|
$38,680 | — | 30 Jun 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.07%
|
43,647
|
$35,327 | — | 30 Jun 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.07%
|
42,573
|
$34,459 | — | 30 Jun 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.06%
|
41,747
|
$33,815 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.06%
|
39,977
|
$32,357 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.06%
|
38,127
|
$30,860 | — | 30 Jun 2025 | |
| Cerity Partners LLC |
13F
|
Company |
0.06%
|
36,393
|
$29,457 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.05%
|
33,625
|
$27,216 | — | 30 Jun 2025 | |
| Christopher Pierce |
3/4/5
|
EVP and Chief of Business Oper |
—
mixed-class rows
|
211,546
mixed-class rows
|
$14,138 | — | 02 Sep 2021 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.03%
|
17,411
|
$13,930 | — | 30 Jun 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.03%
|
16,799
|
$13,597 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
11,293
|
$9,136 | — | 30 Jun 2025 | |
| FMR LLC |
13F
|
Company |
0.02%
|
11,167
|
$9,039 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
8,602
|
$6,963 | — | 30 Jun 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.01%
|
4,718
|
$3,819 | — | 30 Jun 2025 | |
| CWM, LLC |
13F
|
Company |
0.01%
|
4,014
|
$3,000 | — | 30 Jun 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
2,741
|
$2,219 | — | 30 Jun 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
2,781
|
$2,000 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
1,949
|
$1,577 | — | 30 Jun 2025 | |
| NISA INVESTMENT ADVISORS, LLC |
13F
|
Company |
0%
|
1,634
|
$1,323 | — | 30 Jun 2025 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0%
|
1,180
|
$956 | — | 30 Jun 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
500
|
$405 | — | 30 Jun 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
297
|
$240 | — | 30 Jun 2025 | |
| EverSource Wealth Advisors, LLC |
13F
|
Company |
0%
|
148
|
$120 | — | 30 Jun 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
52
|
$42 | — | 30 Jun 2025 | |
| IFP Advisors, Inc |
13F
|
Company |
0%
|
34
|
$28 | — | 30 Jun 2025 |
Institutional Holders of Prelude Therapeutics Inc - Common Stock, $0.0001 par value per share (PRLD) as of Q3 2025
As of 30 Sep 2025,
Prelude Therapeutics Inc - Common Stock, $0.0001 par value per share (PRLD) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,161,835 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, BAKER BROS. ADVISORS LP, MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, RENAISSANCE TECHNOLOGIES LLC, ACADIAN ASSET MANAGEMENT LLC, MORGAN STANLEY, BlackRock, Inc., and TWO SIGMA ADVISERS, LP.
This page lists
45
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
49
Q3 2025 holders
45
Holder diff
-4
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.